Should I buy CareTrust REIT (CTRE) stock or is it too late?
⭐ The most reliable of them, either direction: Cantor Fitzgerald — 62% of its targets hit on this sector (13 calls tested). It aims for $43 (+18 %), call made on August 11, 2026, maturing on August 11, 2027 (64 d ago).
Firm-by-firm track record on CareTrust REIT
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wells Fargo | 100 % | +27.9 % | 9 | $44 +20% |
| RBC Capital | 86 % | +24.0 % | 7 | $43 +18% |
| Keybanc | 91 % | +20.6 % | 11 | $40 +9% |
| Raymond James | 100 % | +19.3 % | 8 | $42 +15% |
| BMO Capital | 83 % | +13.7 % | 6 | $45 +23% |
✅ Reasons to believe
- 67% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
- Median price target $43, i.e. +18% from the current price ($37).
- The most reliable firm on CTRE, Wells Fargo (100% hit rate, 9 scored calls), targets $44 (call made on September 1, 2026, maturing on September 1, 2027) (+20%) in its most recent call, and $41 (call made on November 25, 2025, maturing on November 25, 2026) (+12%) in the one coming due soonest.
- Pays a dividend (3.5% yield), raised for 6 years — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 6 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on CTRE
Median target $43 (+18%) · 6 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in CareTrust REIT now?
We won't decide for you. The facts: 67% of analysts rate it a buy, median target $43 (+18%), and Wells Fargo (most reliable on CTRE, 100%) targets $44. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in CareTrust REIT?
Not according to analysts: the median target ($43) is still +18% above the current price ($37) (most reliable on CTRE: Wells Fargo, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is CareTrust REIT still worth investing in?
It depends on the gap between the price ($37) and its estimated value: analysts target $43 on median (+18%), with 67% buys (most reliable on CTRE: Wells Fargo, 100%). Cross-check with their real reliability on CTRE and the cautions above. Information, not advice.
What's the main risk in buying CTRE?
The consensus is not unanimous: of 6 ratings, 2 are neutral.
→ Go deeper: the full CareTrust REIT profile (consensus, analyst reliability, price target, performance).